Back to Market Feed

Historical record - last NADAC effective date: 3/20/2019

Product Information

TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $3.6356 per EA under NDC 68462032901. Its NADAC has been published 167 times since May 18, 2016.

FDA first approved this application on May 5, 2010.

TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET

Trandolapril and Verapamil Hydrochloride
$3.6356per EA

Strength

4; 240 mg/1; mg/1

NDC

68462032901

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

3/20/2019

Approval Type

Generic (ANDA)

FDA Application

ANDA079135

FDA Approved

5/5/2010

On Market Since

2/25/2015

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET has been published 167 times since May 18, 2016, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.

Current price$3.6356 per EA
All-time high$4.0543 (Sep 13, 2017)
All-time low$3.6356 (Aug 22, 2018)
Median price$3.8248
Average price$3.8205
Largest weekly change-8.9% (Aug 22, 2018)
Weeks tracked167
Tracking sinceMay 18, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-5.4%

Last surveyed Aug 14, 2019 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Trandolapril and Verapamil Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

AMLODIPINE BESYLATE 5 MG TAB
Generic
00480716710•Teva Pharmaceuticals USA Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
00904637061•Major Pharmaceuticals
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
29300039705•Unichem Pharmaceuticals (USA) Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
29300039710•Unichem Pharmaceuticals (USA) Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
29300039719•Unichem Pharmaceuticals (USA) Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
42806005605•Epic Pharma LLC
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
42806005609•Epic Pharma LLC
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
42806005610•Epic Pharma LLC
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
59762201001•Mylan Pharmaceuticals Inc.
$0.0101
per EA
AMLODIPINE BESYLATE 5 MG TAB
Generic
59762201003•Mylan Pharmaceuticals Inc.
$0.0101
per EA

Frequently asked questions

What is the NADAC price of TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $3.6356 per EA (NDC 68462032901), effective Aug 14, 2019.

How has the price of TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET changed over time?

Over the history we have for it, the NADAC for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET has declined 5.4%. It has been tracked across 167 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?

Since May 18, 2016, the NADAC for TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET has ranged from a low of $3.6356 (Aug 22, 2018) to a high of $4.0543 (Sep 13, 2017), with a median of $3.8248 per EA.

Are there cheaper alternatives to TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET?

TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET (NDC 68462032901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.